FTEAA is a 4-styrylpiperidine inhibitor. FTEAA exhibits potent inhibitory effect towards both monoamine oxidase with IC50s of 0.52 µM (MAO-A), 1.02 µM (MAO-B), respectively. MAO inhibitors can be used for cardiovascular, neurological and oncological disorders research[1][2].
Molecular Weight:
646.57
Formula:
C34H26F8N2O2
Target:
Monoamine Oxidase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
